Total Funding
33
66
Total FundingSeed raised
Growth Score 33 in past quarter
-3 pts
Heat Score 66 in past quarter
-20 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
39628
Valted Seq is a discovery stage biopharmaceutical company that utilizes big data to develop lifesaving therapeutics.
- Ted Dawson: Co-Founder
- Valina L. Dawson: Founder
About the Company
Valted Seq is a discovery stage biopharmaceutical company that utilizes big data to develop lifesaving therapeutics.
focused on the discovery of neurodegenerative pathways and biomarkers to inform and accelerate the development of new therapeutics and diagnostics, including companion diagnostics which play a critical role in enabling advanced
therapeutics. To achieve this, the company has created the world’s largest repository of single-cell sequencing data from high-quality, clinically characterized brain tissues of patients with neurodegenerative diseases including Alzheimer’s and Parkinson’s.
It was established in Gaithersburg, Maryland by
Women Founded
Women Led